Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Umbilical Cord Mesenchymal Stem Cells (Alliancells Bioscience)
- Development stage
- Unknown
- Lead developer
- Alliancells Bioscience
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) developed by Alliancells Bioscience Corporation Limited are an allogeneic cell therapy candidate being investigated for the treatment of liver cirrhosis. These multipotent cells are derived from umbilical cord tissue and are characterized by their ability to modulate the immune system and promote tissue repair. In patients with liver cirrhosis, UC-MSCs are administered intravenously to migrate to the liver, where they aim to suppress chronic inflammation, inhibit the activation of hepatic stellate cells responsible for fibrosis, and stimulate the regeneration of functional hepatocytes. This approach seeks to improve liver function and halt or reverse the progression of cirrhotic damage, particularly in cases resulting from alcohol abuse or viral hepatitis.
- Other names
- Umbilical Mesenchymal Stem CellsUC-MSCmesenchymal stem cells
Beyond the preview
Go deeper on Umbilical Cord Mesenchymal Stem Cells (Alliancells Bioscience).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Umbilical Cord Mesenchymal Stem Cells (Alliancells Bioscience).